Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

74 results about "Mycoplasmal pneumonia" patented technology

Special diluent for swine mycoplasmal pneumonia vaccines and preparation method of special diluent

The invention discloses a special diluent for swine mycoplasmal pneumonia vaccines. The special diluent mainly contains a recombinant P97R1 protein immunostimulating complex (ISCOM-P97R1); and in addition, the special diluent also possibly contains other water-based adjuvants comprising levomisole, astragalus polysaccharide or/and carbomer. 1 ml of diluent solution contains 0.1-1 mg of QuilA, 0.02-0.2 mg of cholesterol, 0.02-0.2 mg of phosphatidylcholine and 0.4-4 mg of P97R1 antigen; and in addition, 1 ml of diluent solution also possibly contains 2-20 mg of levomisole, 20-100 mg of astragalus polysaccharide or/and 3-10 mg of carbomer and a phosphate buffer solution for the rest. The diluent is specially used for dissolving or diluting the swine mycoplasmal pneumonia vaccines comprising a live vaccine and an inactivated vaccine, has the double effects of complementing vaccine antigen protection spectrums and improving the vaccine cell and humoral immunostimulation capability, can remarkably improve the toxic attack protection efficacy of the vaccines, and also has the advantages of being simple and convenient to operate, good in syringeability and free from remarkable toxic side reaction due to the adoption of a hydrosolvent system at the same time.
Owner:JIANGSU ACADEMY OF AGRICULTURAL SCIENCES

Feed for preventing and treating mycoplasmal pneumonia of swine and traditional Chinese medicine composition as well as preparation method

The invention discloses feed for preventing and treating mycoplasmal pneumonia of swine and a traditional Chinese medicine composition as well as a preparation method. The feed comprises a feed carrier, a feed adhesive and the traditional Chinese medicine composition, wherein the traditional Chinese medicine composition comprises meadowrue root and rhizome, common andrographis herb, cordate houttuynia, wild buckwheat rhizome, calyx seu fructus physalis, agilawood, perillaseed, fingered citron, bulbus fritillariae cirrhosae, snakegourd fruit, rhizoma anemarrhenae, bamboo juice, tabasheer, platycodon grandiflorum, concha meretricis seu cyclinae, bryozoatum, aster, birthwort, folium eriobotryae, herba ardisiae japonicae, folium rhododendri daurici, radix astragali, liquorice, herb of little platanthera, pueraria montana merr and all-grass of longsepaled crotalaria. The feed has the beneficial effects that the feed overcomes various defects of traditional Chinese medicines and western medicines in the prior art, has the effects of clearing heat and eliminating phlegm, relieving cough and asthma, strengthening body resistance and eliminating evil on treatment of mycoplasmal pneumonia of swine and has a remarkable clinical effect, is high in curative ratio and has no toxic or side effects and no drug residue, no drug resistance is generated by using the feed, and the mycoplasmal pneumonia of swine is difficult to relapse by using the feed; in addition, the feed is capable of improving the immunity of organisms of ill pigs and is low in cost, and meat of pigs fed by using the feed has a certain health effect on bodies of customers eating the meat.
Owner:SHANDONG NEW HOPE LIUHE GROUP

Collaborative multiplex PCR detection method for nucleic acids of nine respiratory tract pathogens

The invention discloses a collaborative quadruple real-time fluorescence PCR detection method for simultaneously detecting target nucleic acids of nine pathogens by using three PCR reaction tubes. Themethod is used for detecting influenza A virus (FluA), influenza B virus (FluB), parainfluenza virus (PIV), respiratory syncytial virus (RSV), mycoplasma pneumoniae (MP), chlamydia pneumoniae (Cpn),adenovirus (ADV), human rhinovirus (HRV) and human metapneumovirus (hMPV) in samples. The method is rapid to operate, can be completed by one-step cooperation and has high sensitivity. In addition, the invention also relates to a reagent involved in the PCR method, a detection kit used for the method, preparation and application of the detection kit and the like.
Owner:苏州华益美生物科技有限公司

Nanoemulsion composition for treating mycoplasma pneumonia of livestock and preparation method of nanoemulsion composition

The invention discloses a nanoemulsion composition for treating mycoplasma pneumonia of livestock, which consists of raw materials including, by mass percent, from 0.1 to 8.0% of amyris oil, from 0.1 to 5.0% of vitex oil, from 0.1 to 3.0% of perilla oil, from 0.1 to 2.0% of bupleurum oil, from 0.01 to 0.1% of allicin, from 0.1 to 4.0% of tiamulin fumarate, from 19.0% to 31.0% of surfactant and the balance distilled water. The sum of the mass ratios of the ingredients is 100%. The nanoemulsion composition has effects of dilating the trachea of the livestock, suppressing cough reflex, increasing immunity of the organism, resisting inflammation and killing mycoplasma pneumoniae or other mixed infected causative agent, can be used for preventing and curing respiratory diseases including chronic respiratory diseases of the livestock, mycoplasma pneumoniae of swine, porcine contagious pleuropneumonia and the like, is fine in stability, is high in intestinal absorption utilization rate after being orally taken, can avoid liver first pass effect, and is remarkable in curative effect.
Owner:NORTHWEST A & F UNIV

Preparation method, formula and use method of bovine mycoplasma pneumonia inactivated vaccine

The invention provides a preparation method, a formula and a use method of a bovine mycoplasma pneumonia inactivated vaccine. The preparation method of the bovine mycoplasma pneumonia inactivated vaccine comprises the following steps: 1, selecting diseased cattle which naturally infect mycoplasma pneumonia and is dying, taking diseased lungs, lymph glands and spleens to homogenize and removing precipitates and grease through filtering and centrifugation to obtain an antigen solution; 2, adding formaldehyde into the antigen solution to inactivate for 72 hours, adding 1,000 units of penicillin and 1,000 units of streptomycin into the antigen solution per millimeter and uniformly mixing to obtain an inactivated antigen solution; 3, mixing the inactivated antigen solution with an aluminum hydroxide adjuvant according to the proportion of 4:1 to obtain the inactivated vaccine. The vaccine prepared by the preparation method is safe in application, strong in pertinence and indeed in immune protection effect on mycoplasma causing bovine pleuropneumonia by infection, the lung lesion score of the infected cattle can be obviously reduced, the material weight ratio is improved, and the good effects of prevention and disease control can be achieved.
Owner:福清市默克兽医院

Medicine composition for treating mycoplasmal pneumonia and preparation method thereof

The invention discloses a medicine composition for treating mycoplasmal pneumonia and a preparation method thereof. The medicine composition comprises the raw materials of lobelia, herbs of threeflower bluebeard, fructus aurantii, great burdock achene, stemona tubers, balloon flowers, meadowrue roots and rhizomes, heartleaf houttuynia herbs, liquorice, Japanese ardisia, Japanese metaplexis, Indian Kalimeris herbs, ginger, thorny elaeagnus fruits, magnetite, Russian boschniakia herbs, bamboo juice, plantain seeds, white mustard seeds, narrow-leaf lepisorus, tabasheer, perilla fruits, agilawood, white mulberry root-bark, raspberries, immature fruits of medicine terminalia, pepperweed seeds, sharpleaf galangal fruits, pennycress, woody hawkbeard roots, wallich eriophyton and lemmaphyllum subrostratum. The medicine composition has the advantages that the effects of clearing away heat through releasing the lungs, regulating the lungs, relieving asthma and reducing phlegm are achieved, meanwhile, the effects of tonifying the kidneys, removing blood stasis, promoting urination and replenishing vital essence to cultivate qi are achieved, the medicine composition takes effect rapidly, is high in effective rate and free of toxic and side effects and has a definite treatment effect, the treatment course is short, and the price is low.
Owner:吴强

Traditional Chinese medicine composition used for preventing and treating mycoplasmal pneumonia of swine as well as preparation method and application thereof

The invention discloses a traditional Chinese medicine composition used for preventing and treating mycoplasmal pneumonia of swine. The traditional Chinese medicine composition comprises the following components in parts by weight as main active components: 20-30 parts of herba houttuyniae, 15-25 parts of membranous milkvetch roots, 15-25 parts of radix stemonae, 15-20 parts of platycodon grandiflorum, 15-20 parts of garlic, 10-20 parts of rhizoma anemarrhenae, 10-15 parts of ephedra, 10-15 parts of roots of redroot gromwell, and 5-10 parts of radix glycyrrhizae. The invention also discloses a preparation method and application of the traditional Chinese medicine composition. Tests show that the traditional Chinese medicine composition can inhibit in-vitro growth of mycoplasma hyopneumoniae, can well control the mycoplasma hyopneumoniae for infection and pathogenicity of mice, and is clinically used for preventing and treating infection and pathogenicity of the mycoplasma hyopneumoniae, has a good pharmaceutical effect and no toxic or side effects, and is convenient to take.
Owner:HUNAN TAIFENG ANIMAL PHARMA

Compound florfenicol powder for animals and preparation thereof

The invention discloses a veterinary compound florfenicol powder and a preparation method thereof, which aims at providing the veterinary compound florfenicol powder that has rapid onset of action for the treatment for porcine infectious pleuropneumonia and mycoplasmal pneumonia and can treat both manifestation and root causes of the diseases, alleviate the stress reactions when having the attacks of diseases of the pigs and improve the weight gain rate, and the preparation method that has simple process and easy realization. The powder is composed of the components with the following weight percentages: 5 to 20 percent florfenicol, 0.5 to 5 percent doxophylline and the rest of starch. The powder of the invention is a compound preparation which combines anti-bacterial drugs and the drugs for relieving cough and asthma, the florfenicol and the doxophylline are combined for usage, thus having rapid onset of action for the treatment for infectious pleuropneumonia and mycoplasmal pneumonia, effectivity and high efficiency; furthermore, the power can ease the stress reactions of the affected animals, significantly ease the clinical symptoms caused by the infectious pleuropneumonia and the mycoplasmal pneumonia, treat both manifestation and root causes of diseases, reduce the suffering of the affected pigs and increase the weight of the pigs.
Owner:天津市海纳德动物药业有限公司

Construction method of sheep mycoplasmal pneumonia bivalent nucleic acid vaccine containing adjuvant gene

PendingCN113444743AEffective against weak immunity and other problemsSolve many problems faced by R&DAntibacterial agentsAntibody mimetics/scaffoldsMycoplasmal pneumoniaTGE VACCINE
The invention discloses a construction method of a sheep mycoplasmal pneumonia bivalent nucleic acid vaccine containing an adjuvant gene. The construction method comprises the following specific steps of: step 1, extraction of a Mo / Mmc genome: S1, recovery and culture of a Mo / Mmc Guizhou strain, and S2, extraction of the DNA of the Mo / Mmc Guizhou strain; step 2, amplifying a P113-LppA-IL-2 fusion gene: S1, amplification of a mucosal immunologic adjuvant gene and mycoplasma ovipneumoniae and Mycoplasma mycoides subsp. Capri antigen gene, S2, the amplification of the P113-LppA fusion gene, and S3, the amplification of the P113-LppA-IL-2 fusion gene; and step 3, preparing the sheep mycoplasmal pneumonia bivalent nucleic acid vaccine containing the mucosal immunologic adjuvant gene. According to the construction method disclosed by the invention, the nucleic acid vaccine is developed by selecting two different antigen genes and mucosal immunologic adjuvant genes, so that the problems of a weak immune effect and the like of the sheep mycoplasmal pneumonia DNA vaccine can be effectively solved, and many problems confronted by current vaccine research and development are solved.
Owner:GUIZHOU UNIV

Selective separation medium for caprine mycoplasmal pneumonia subspecies and preparation method of selective separation medium

The invention relates to a selective separation medium for caprine mycoplasmal pneumonia subspecies and a preparation method of the selective separation medium, and belongs to the technical field of veterinary biology. The selective separation medium is prepared from components as follows: lactoalbumin hydrolysate, yeast extract powder, glucose, an MEM medium, a PPLO (pleuropneumonia-like organism) gravy powder, sodium pyruvate, a 1% phenol red solution, specific growth inhibition serum and deionized water. The preparation method comprises steps as follows: the lactoalbumin hydrolysate, the yeast extract powder, glucose, the MEM medium, the PPLO gravy powder, sodium pyruvate and the 1% phenol red solution are weighed in proportion and dissolved in the deionized water. Before use, healthy horse serum and the specific growth inhibition serum are added. The selective separation medium for the caprine mycoplasmal pneumonia subspecies is used for clinically separating and cultivating the caprine mycoplasmal pneumonia subspecies, increases the growth speed of mycoplasma in a separation process and increases the separation rate of the caprine mycoplasmal pneumonia subspecies, and the separation rate is 80% or higher.
Owner:SHANDONG BINZHOU ANIMAL SCI & VETERINARY MEDICINE ACADEMY

Acetylisovaleryltylosin tartrate formulation preparation method and prepared acetylisovaleryltylosin tartrate formulation thereof, and pharmaceutical composition

The present invention provides an acetylisovaleryltylosin tartrate formulation preparation method, which comprises: (1) adding a wall material to water, and dissolving to prepare a binder solution, wherein the wall material comprises polylactic acid and arabic gum according to a ratio of 1:1; (2) adding an acetylisovaleryltylosin tartrate core material to the binder solution, and uniformly mixing to prepare a mixture; and (3) carrying out spray drying of the mixture prepared in the step (2) to prepare the acetylisovaleryltylosin tartrate formulation. According to the present invention, the acetylisovaleryltylosin tartrate formulation prepared through the method is stable and lastly act, and the cure rate is extremely high when the composition comprising the acetylisovaleryltylosin tartrate formulation and doxycycline is used to treat swine mycoplasma pneumonia.
Owner:LUOYANG HUIDE BIO ENG CO LTD

Chinese medicinal injection with heat-clearing and detoxication, cough and asthma relieving efficacy

The invention relates to a traditional Chinese medicine compound injection with the effects of clearing heat, removing toxicity, stopping cough and calming asthma, including three medicines of Chinese lobelia herb, Philippine violet herb and honeysuckle flower. The invention is mainly used for livestock respiratory diseases. The invention is applicable to livestock virus flu, mycoplasmal pneumonia, bronchitis, lobar pneumonia and other diseases which are caused by viral and bacterial infections and flu and are accompanied with dyspnoea, cough, asthma, runny nose and other symptoms. The formula of the invention has the effects of clearing heat, removing toxicity, stopping cough and calming asthma. The medicine is prepared into the injection by the combination of the special physiological structure of the livestock, and the invention can be absorbed rapidly after muscle injection, so as to achieve the purpose of rapid onset of action.
Owner:TIANJIN RINGPU BIO TECH

Quality control material for detecting respiratory tract pathogen nucleic acid and preparation method thereof

The invention provides a quality control material for detecting respiratory pathogen nucleic acid. The quality control material comprises any one or more of the following respiratory pathogens: coronavirus, influenza virus, adenovirus, mycoplasma pneumoniae, streptococcus pneumoniae, rhinovirus or / and legionella pneumophila. A full-length genome sequence of the coronavirus is divided into six target fragments, and the length of each fragment ranges from 4000 bp to 5500 bp. The quality control material disclosed by the invention covers all detection target sequences (or target spots) of the coronavirus, the coverage is wide, the detection target spots are comprehensive, and the phenomenon of missing detection is avoided. The quality control material provided by the invention contains main respiratory tract infection pathogens, has a wide coverage range, and has more accurate detection targets by taking a real virus sample and a slow virus sample as raw materials. According to the coronavirus quality control material prepared by the invention, a target gene sequence is integrated into a host genome through a lentiviral vector, an autonomously replicated gene is knocked out in the preparation process, and the coronavirus quality control material has a self-inactivation capability, so that the recombinant lentivirus cannot be replicated in a target cell and infects other cells.
Owner:GUANGZHOU BDS BIOLOGICAL TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products